Results for tag: "Achromatopsia Drug"

Achromatopsia Drug is a type of drug used to treat achromatopsia, a rare genetic disorder that causes complete or partial color blindness. The drugs are designed to improve the vision of those affected by the disorder, allowing them to see colors more clearly. The drugs work by targeting the underlying cause of the disorder, which is a mutation in the CNGB3 gene. The drugs are typically administered orally or through eye drops. The Achromatopsia Drug market is relatively small, as the disorder is rare and affects only a small number of people. However, the market is growing as more research is conducted into the disorder and new treatments are developed. Some companies in the Achromatopsia Drug market include Acucela, Inc., Ocuphire Pharma, Inc., and Ophthotech Corporation. Show Less Read more